Delivery of Survivorship Care by Primary Care Physicians: The Perspective of Breast Cancer Patients

Jun J. Mao(Memorial Sloan Kettering Cancer Center), Katrina Armstrong(Columbia University), Marjorie A. Bowman(United States Department of Veterans Affairs), Carrie Tompkins Stricker(University of Pennsylvania Health System), Dingyun Chan(University of Pennsylvania Health System), Linda A. Jacobs(Abramson Cancer Center), Angela DeMichele(University of Pennsylvania)
Journal of Clinical Oncology
January 13, 2009
10.1200/jco.2008.18.0679
Cited by 179

Related Papers

Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone-receptor-positive, HER2-negative metastatic breast cancer that progressed on previous endocrine therapy (PALOMA-3): final analysis of the multicentre, double-blind, phase 3 randomised controlled trial
|The Lancet Oncology|2016|1.8k
Overall Survival with Palbociclib and Fulvestrant in Advanced Breast Cancer
|New England Journal of Medicine|2018|1.3k
American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline
|Journal of Clinical Oncology|2015|1k
SARS-CoV-2 viral load is associated with increased disease severity and mortality
|Nature Communications|2020|981
American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline
|CA A Cancer Journal for Clinicians|2015|737